Single agent docetaxel plus granulocyte-colony stimulating factor (G-CSF) in previously treated patients with advanced non small cell lung cancer. A phase II study and review of the literature. [electronic resource]
Producer: 20000531Description: 1077-84 p. digitalISSN:- 0250-7005
- Adult
- Aged
- Antineoplastic Agents, Phytogenic -- adverse effects
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Deoxycytidine -- analogs & derivatives
- Docetaxel
- Drug Administration Schedule
- Female
- Granulocyte Colony-Stimulating Factor -- adverse effects
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Staging
- Paclitaxel -- adverse effects
- Survival Analysis
- Taxoids
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Review
There are no comments on this title.
Log in to your account to post a comment.